We are recruiting Alzheimer’s disease participants.
We are recruiting participants for a study of the eye and the role of NMDA
receptors in Alzheimer’s disease when a treatment decision regarding NAMENDA
has been made.
The study does not suggest or interfere with management, and participants
can already be on an acetylcholinesterase inhibitor. We would
evaluate participants after treatment decisions regarding NAMENDA are made, but
prior to a participant starting to take the medication. A complete eye
examination is performed just prior to going on NAMENDA.
In addition to a complete eye examination, Optical Coherence Tomography
(OCT), a photography type image of the inside of the eye, and Frequency
Doubling Technology (FDT), a very simple side vision/peripheral test, are done.
The tests are repeated two additional times.
Examinations can be done at the Boston
Medical Center Boston University Eye Associates (BUEA) at Boston
University. They can also
be done at the BUEA Brockton clinic located across from the Westgate Mall in Brockton.
Contact: Denise A. Valenti, OD, 617-638-4558 mailto:email@example.com - firstname.lastname@example.org